Electronic Component News
Published on Electronic Component News (https://www.ecnmag.com)

Home > Vialipro Dietary Supplement: Recall-Undeclared Drug Ingredient

Vialipro Dietary Supplement: Recall-Undeclared Drug Ingredient

[Posted 07/20/2010]

AUDIENCE: Consumers

ISSUE: Good Health, Inc. is conducting a voluntary recall after an FDA lab analyses found that the product tested from certain batches of Vialipro contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED) making this product an unapproved drug. The undeclared ingredient may pose a threat to the consumer because the interaction of the analogue with some prescription drugs (such as nitroglycerin) may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take other prescription drugs.

BACKGROUND: This product is currently being sold as a dietary supplement throughout the U.S.  The affected lot numbers being recalled can be found in the company's Press Release.

RECOMMENDATION: Consumers who have purchased Vialipro should discontinue its use and return it to Good Health, Inc.

Report adverse events or side effects related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Online: www.fda.gov/MedWatch/report.htm [1]
  • Phone: 1-800-332-1088
  • Mail: return the postage-paid FDA form 3500, which may be downloaded from the MedWatch "Download Forms" page, to address on the pre-addressed form
  • Fax: 1-800-FDA-0178

[07/16/2010 - Press Release [2] - Good Health, Inc.]

    

SOURCE [3]

Content Item Type: 
News [4]
Meta Canonical URL: 
http://www.ecnmag.com/news/2010/07/vialipro-dietary-supplement-recall-undeclared-drug-ingredient
Summary: 
Lab analyses found that certain batches of Vialipro contain Sulfoaildenafil, an analogue of Sildenafil.
Contributed Author: 
FDA MedWatch
Topics: 
Electronics [5]
Legacy NID: 
130 339

Connect with ECN

  • Facebook
  • Twitter
  • YouTube

Resources

  • About Us
  • Advertising Info
  • Contact Us
  • Contributor Guidelines
  • Digital Editions
  • Directory FAQs
  • Privacy Policy
  • Product Announcement Form
  • Subscriptions
  • Terms & Conditions

Topics

  • Automotive
  • Consumer
  • Displays
  • Electronics
  • Government
  • Industrial
  • Medical
  • Mil/Aero
  • Power
  • STEM
  • Sensors

© Copyright 2018 Advantage Business Marketing

(function() { var _fbq = window._fbq || (window._fbq = []); if (!_fbq.loaded) { var fbds = document.createElement('script'); fbds.async = true; fbds.src = '//connect.facebook.net/en_US/fbds.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(fbds, s); _fbq.loaded = true; } _fbq.push(['addPixelId', '745881082149515']); })(); window._fbq = window._fbq || []; window._fbq.push(['track', 'PixelInitialized', {}]);
var _qevents = _qevents || []; (function() { var elem = document.createElement('script'); elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js"; elem.async = true; elem.type = "text/javascript"; var scpt = document.getElementsByTagName('script')[0]; scpt.parentNode.insertBefore(elem, scpt); })(); _qevents.push({ qacct:"p-jsEPJWTckjCbE" });
Quantcast
Advertisement
googletag.cmd.push(function() { googletag.display("dfp-ad-clone_of_wallpaper"); });

Deeper Insights

<% if ( rc.ss_related_image_url != null ){ %>
?cmpid=regwallcontent&utm_source=Deeper%20Insights">">
<% } %>

?cmpid=regwallcontent&utm_source=Deeper%20Insights" + ""><%- rc.label %>

<% if ( rc.ss_search_logo != null ){ %>
">
<% } %>
(function(d,s,i,r) { if (d.getElementById(i)){return;} var n=d.createElement(s),e=d.getElementsByTagName(s)[0]; n.id=i;n.src='//js.hs-analytics.net/analytics/'+(Math.ceil(new Date()/r)*r)+'/1743435.js'; e.parentNode.insertBefore(n, e); })(document,"script","hs-analytics",300000);
(function(a, b, c, f, g, h, i, j, w, y) { this.a = a; this.b = b; this.c = c; var s = document.createElement("script"); s.id = "mzb-detect"; s.async = "1"; s.type = "text/javascript"; s.src = "//" + this[y] + h + f + g + "?" + "1&49338851892"; (i || j).appendChild(s) })("d1ssbq1bwjg5ux", "d3vfi478lf07xt", "d1rnw04e6mc22h", String.fromCharCode(65 + ~~(Math.random() * (90 - 65))), Math.random().toString(36).substring(2, 7), ".cloudfront.net/", document.head, document.body, window, String.fromCharCode(97 + Math.floor(Math.random() * 3 + 0)));
googletag.cmd.push(function () { googletag.display("dfp-ad-roadblock_modal"); });
"" style="border: 0px; vertical-align: bottom;">
googletag.cmd.push(function() { googletag.display("dfp-ad-roadblock_modal"); });

Source URL: https://www.ecnmag.com/news/2010/07/vialipro-dietary-supplement-recall-undeclared-drug-ingredient

Links
[1] http://www.fda.gov/MedWatch/report.htm
[2] http://www.fda.gov/Safety/Recalls/ucm219558.htm
[3] http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm219580.htm
[4] https://www.ecnmag.com/content-item-types/news
[5] https://www.ecnmag.com/topics/electronics